Life Science Capital Markets shutterstock 1881178267

Life Science Capital Markets

Newmark's Life Science Capital Markets practice unites experts in investment sales and leasing, bringing an integrated approach to the nation's leading life science markets.

Overview

Anchored by a commanding presence and significant market share in life science hubs on both coasts, Newmark combines in-depth knowledge of the industry's capital and operational aspects to drive unmatched productivity.

We begin by assembling an in-house team of global real estate experts tailored specifically to your asset's unique needs. Our comprehensive approach to the sale, acquisition, and financing of life science properties is led specialists in laboratory, biomanufacturing, clinical research, and biotech assets. At the same time, the industry's top leasing experts provide buyers and sellers with up-to-the-minute strategic insights, to best navigate the industry’s rapidly changing landscape.



Our Services

  • Investment sales

  • Representation services regarding the sale and acquisition of life science properties

  • Portfolio optimization

  • Financial and market analysis

  • Build-to-suit forward sales and financing

  • Corporate sale leaseback advisory and transactional services

  • Developer services, including equity, debt and structured finance

  • Buyer financial solutions, including credit tenant lease financing



Our Clients

We regularly represent owners and buyers of life science properties, including:

  • Public and private REITs

  • Private equity funds

  • Research institutions, hospitals and universities

  • Government

  • IRC §1031 exchange investors

  • Real estate developers

  • Institutional owners

  • High net worth individuals

  • Private funds

  • Individual owners

  • International real estate funds